Innerskin secures USD 15M to drive European expansion
This funding round reflects a broader shift in the European beauty and personal care ecosystem, where investment is increasingly targeting end-to-end aesthetic wellness providers rather than just isolated enabling technologies or ingredient sustainability.
FRANCE – Innerskin, a Paris-based medical aesthetics group, has secured €12.8 million (USD 15 million) in a recent funding round led by IRIS Ventures, with participation from existing investors including Label Capital.
The funding will be used to expand Innerskin’s holistic approach to modern aesthetics, which combines clinical precision with lifestyle appeal.
The company’s model links in-clinic aesthetic services with a medical-grade skincare line, creating a seamless ecosystem that builds trust, delivers results, and fosters brand loyalty.
Innerskin stands out in the European market by offering a comprehensive, vertically integrated solution that merges premium beauty, medical-grade performance, and wellness under one elevated brand.
Founded in 2022 by Chrystelle Eid, Innerskin has rapidly opened 19 centers in France, focusing on preventive face and body care.
The company leverages high-performance technology, holistic expertise, and a premium customer experience to meet the evolving needs of today’s consumers.
Its approach connects skincare with non-invasive treatments, combining clinical precision with lifestyle appeal, and emphasizes personalized treatment programs using advanced non-invasive technologies such as resurfacing lasers, chemical peels, targeted injections, radiofrequency treatments, cryolipolysis, and Hollywood peels.
Innerskin’s success demonstrates growing consumer demand for science-based, transparent, and holistic self-care experiences, positioning the company as a leader in transforming modern aesthetics and skin health in Europe.
Conscious Chemist raises USD 1.8M bridge round to accelerate D2C skincare expansion
In a similar move, Conscious Chemist, a Bengaluru-based direct-to-consumer (D2C) skincare brand, has secured ₹15 crore (USD 1.8 million) in a bridge funding round led by Atomic Capital, with additional participation from First Port Capital Fund B and IPV International.
The capital raised will be used to strengthen leadership hiring, scale inventory and marketing operations, and support new product development.
Conscious Chemist aims to achieve an annual recurring revenue of ₹500 crore (USD 60.2 million) within the next 24–36 months, with a focus on maintaining sustainable unit economics and solidifying its position as a science-driven beauty brand in India.
The company has reported a 3X revenue growth over the past 12 months and plans to leverage the new funding to enter new categories, including scalp and hair care, while further expanding its digital footprint and quick commerce presence.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
